Integrated Drug Discovery

Integrated Drug Discovery

A truly integrated approach to small molecule drug discovery from hit identification to pre-clinical candidate. Find out more >

Medicinal and Synthetic Chemistry

Medicinal and Synthetic Chemistry

A wealth of experience in all aspects of drug discovery chemistry with a proven track record. Find out more >

CADD

CADD

Accelerate hit-finding with high-throughput docking combined with pharmacophore and similarity searching. Find out more >

Biology

Biology

Comprehensive biology capabilities with expertise ranging from molecular biology to biomarker identification. Find out more >

ADMET/PK

ADMET/PK

A cascade of approaches ranging from early in vitro assessment to in vivo pharmacokinetics. Find out more >

Pharmaceutics

Pharmaceutics

Understanding and de-risking molecules as future pharmaceuticals. Find out more >

Respiratory Models

Respiratory Models

Expert mechanistic and predictive insight into human respiratory diseases. Find out more >

Early Safety Assessment

Early Safety Assessment

Integrated de-risking of drug candidates to identify your most robust molecules. Find out more >

Welcome to Argenta

Argenta is a trusted partner in drug discovery outsourcing. We couple a comprehensive range of discovery services with disease area expertise to provide a compelling combination of scientific excellence and cost-effectiveness.

Argenta is a trusted strategic partner with significant industry experience in providing contract small molecule drug discovery services. Argenta offers a truly integrated approach to undertaking complete drug discovery programmes as well as hit identification, hit-to-lead, and lead optimisation projects. Our industry-seasoned, multi-disciplinary research teams work closely with our clients' scientists to enhance knowledge, add manpower, shorten time to development candidate identification, and increase the value of their drug discovery programmes.

Fast Followers for Respiratory Diseases

Latest News

Next Event

  • Academic Drug Discovery: Programmes and Collaborations

    London, UK

    1 March 2012
    Representing Argenta: Jeremy Billson, David Pallin
    All events »

Innovation. Expertise. Delivered